FBXW7 and neoplasm: In the previous studies, FBXW7 often acted as a tumor suppressor in hepatocellular carcinoma (Imura et al., 2014), colorectal cancer (Fiore et al., 2019; Li et al., 2019), non‐small‐cell lung cancer (Xiao et al., 2018), breast and ovarian cancer cells (Zhao, Wang, Mu, Xu, & Sang, 2017), and others.